Retail investors are currently being fed a fairy tale about Boaz Weinstein’s "hostile" takeover of the Seraphim Space Investment Trust. The mainstream financial press wants you to believe this is a story about a predatory New York hedge fund manager bullying a specialized UK tech fund to get his hands on Elon Musk’s SpaceX shares.
They are wrong.
This isn't a heist. It’s a long-overdue autopsy.
The "bitter feud" narrative is a convenient distraction for fund managers who have spent years incinerating capital while hiding behind the "long-term growth" shield. If you think Saba Capital is the villain here, you don’t understand how closed-end funds (CEFs) actually work, and you definitely don’t understand the toxic math of the London Stock Exchange’s tech sector.
The Myth of the "Activist Predator"
Financial journalists love the word "activist" because it sounds like a riot in a boardroom. In reality, Boaz Weinstein is doing the one thing the board of Seraphim was too terrified or too lazy to do: enforcing the basic laws of supply and demand.
Seraphim Space Investment Trust (SSIT) was trading at a massive discount to its Net Asset Value (NAV). For the uninitiated, that means the market was looking at the fund’s basket of space-tech assets—including its crown jewel, SpaceX—and saying, "We don’t believe your math."
When a fund trades at a 40% or 50% discount to its assets, the market is screaming that the management is incompetent or the valuations are a fantasy. Weinstein isn't "seizing control" to destroy the fund; he’s arbitrage-hunting because the UK market is too stagnant to price private tech assets correctly.
I have watched dozens of these "specialist" trusts languish in London. They raise money during a hype cycle—like the 2021 space boom—and then trap investor capital in illiquid private companies while charging fat management fees. Saba isn't the problem. The structure of the London-listed venture capital trust is the problem.
The SpaceX Distraction
The media fixates on SpaceX because Elon Musk moves needles. They frame the conflict as Saba trying to force a fire sale of SpaceX shares to realize a quick profit.
Here is the nuance the "lazy consensus" misses: SpaceX is actually the only thing keeping the lights on in that portfolio. The real issue isn't the winner; it’s the dozens of other companies in the Seraphim portfolio that are essentially "zombies"—private firms that raised money at astronomical valuations in 2021 and will likely never see an IPO or a meaningful exit.
By targeting the fund, Saba is forcing a conversation about transparency.
- Why is the discount so wide?
- Is the "SpaceX premium" being used to mask the rot in the rest of the portfolio?
- Why should shareholders wait ten years for an exit that might never come?
Traditional analysts say Saba’s move "threatens the UK’s position as a tech hub." This is nonsense. Protecting failing fund structures doesn't help tech; it just protects the fees of the people running them. If a fund cannot maintain a share price that reflects its assets, it deserves to be dismantled. That is how a healthy market functions.
The London Discount is a Choice
The UK investment trust sector is currently a graveyard of good ideas. From digital infrastructure to renewable energy, these trusts are trading at record discounts.
The "professional" advice is always to "wait for the cycle to turn." I’ve seen portfolios lose 60% of their value while managers told investors to "stay the course." Saba Capital doesn't play that game. They use a strategy built on credit default swaps and relative value that doesn't care about your feelings or the "future of British space exploration."
They care about the gap between $1.00 and $0.60.
If you are a shareholder in a fund trading at a 50% discount, and you are angry at the guy trying to close that gap, you are suffering from Stockholm Syndrome. You are defending the people who are losing your money against the person trying to unlock the value they’ve locked away.
The Problem With Private Valuations
Let's talk about the "Net Asset Value" of private tech. In a public company, the price is what the last person paid for a share on the exchange. In a private-equity-heavy trust like Seraphim, the price is whatever a valuation committee says it is based on "comparables" and "internal models."
Imagine a scenario where you own a house, and your neighbor's house sells for half of what it was worth two years ago. You decide your house is still worth the 2021 price because you haven't put it on the market yet. That is the Seraphim portfolio.
SpaceX is a rare exception because it has a secondary market where shares trade frequently. But for the rest of the "Space Tech" portfolio? Those valuations are often marks on a piece of paper. Saba knows this. By seizing control, they can force the board to actually prove what these assets are worth in the cold light of day.
Why the Board Lost
The Seraphim board tried to fight Saba by claiming they were protecting the long-term interests of the space sector. It failed because shareholders aren't philanthropists.
The board’s arrogance was their undoing. They treated the trust like a private club instead of a public vehicle. They ignored the discount for too long, assuming that because they held shares in "cool" companies like SpaceX, the math didn't apply to them.
Weinstein proved it does.
Saba now has the power to reshape the board, stop the bleeding, and potentially return capital to shareholders. This isn't "hostile." It’s an intervention. The UK market needs more of this, not less. We need more "barbarians at the gate" to clean out the trusts that have become nothing more than fee-collection machines for stagnant managers.
The Brutal Truth for Retail Investors
If you’re reading the standard reports, you’re likely being told to avoid these "volatile" situations.
Wrong.
These are the only situations where you can actually make money in a flat market. When a heavyweight like Saba enters the ring, they do the heavy lifting for you. They spend the legal fees. They fight the board. They force the liquidation or the share buyback.
Stop asking if Saba is "good for the industry." Start asking why the industry allowed itself to get so bloated and inefficient that a New York hedge fund could walk in and take the keys.
The Seraphim-Saba saga is a masterclass in why you should never trust a fund manager’s "internal valuation" and why a massive discount to NAV is a signal of management failure, not "market irrationality."
If you want to support the UK tech scene, invest in tech companies. If you want to make money, follow the people who know how to spot a broken trust and have the guts to break it further to get the value out.
The era of hiding behind "complex assets" to justify poor share price performance is over.
Give the keys to Boaz. He’s the only one in the room actually looking at the balance sheet.
